IMIQUIMOD

IMIQUIMOD was reported 2334 times

IMIQUIMOD is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPLICATION SITE LYMPHADENOPATHY 1 1.0000
1 CARCINOMA IN SITU OF PENIS 1 0.0909
2 ORF 2 0.0556
3 CHRONIC PAPILLOMATOUS DERMATITIS 4 0.0548
4 CUTANEOUS T-CELL LYMPHOMA REFRACTORY 1 0.0476
5 APPLICATION SITE PLAQUE 1 0.0435
6 ALCALIGENES INFECTION 1 0.0417
7 ADMINISTRATION SITE ULCER 1 0.0417
8 ACHROMOTRICHIA ACQUIRED 2 0.0408
9 EPIDERMODYSPLASIA VERRUCIFORMIS 6 0.0357
10 ACTINIC CHEILITIS 1 0.0345
11 BASOSQUAMOUS CARCINOMA OF SKIN 2 0.0345
12 VULVAR DYSPLASIA 4 0.0336
13 APPLICATION SITE ULCER 23 0.0325
14 APPLICATION SITE ATROPHY 1 0.0303
15 BAND NEUTROPHIL PERCENTAGE DECREASED 1 0.0303
16 DERMOID CYST 9 0.0270
17 MOLLUSCUM CONTAGIOSUM 14 0.0259
18 INTERVERTEBRAL DISC CALCIFICATION 2 0.0220
19 APPLICATION SITE SCAB 47 0.0217
20 CSF PROTEIN ABNORMAL 1 0.0217
21 CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS 9 0.0201
22 APPLICATION SITE NECROSIS 2 0.0194
23 CYTOKINE ABNORMAL 1 0.0192
24 ACANTHOMA 1 0.0192
25 APPLICATION SITE INFLAMMATION 24 0.0173
26 ANOGENITAL WARTS 15 0.0168
27 BACTEROIDES TEST POSITIVE 1 0.0152
28 ACANTHOLYSIS 1 0.0152
29 APPLICATION SITE DISCHARGE 17 0.0147
30 CARDIAC PACEMAKER REMOVAL 1 0.0147
31 AUTOIMMUNE RETINOPATHY 1 0.0137
32 ALCOHOLIC SEIZURE 1 0.0135
33 BASOSQUAMOUS CARCINOMA 2 0.0134
34 BONE METABOLISM DISORDER 4 0.0133
35 SKIN DEPIGMENTATION 17 0.0125
36 APPLICATION SITE EROSION 16 0.0124
37 GRANULOMATOUS DERMATITIS 3 0.0123
38 ADMINISTRATION SITE WARMTH 1 0.0122
39 APPLICATION SITE BLEEDING 3 0.0121
40 LOCAL REACTION 9 0.0121
41 ADMINISTRATION SITE INFLAMMATION 1 0.0111
42 POROKERATOSIS 2 0.0109
43 APPLICATION SITE SCAR 13 0.0104
44 MACULAR SCAR 2 0.0103
45 APPLICATION SITE HYPERAESTHESIA 1 0.0101
46 PERIORBITAL DISORDER 2 0.0098
47 ADENOCARCINOMA METASTATIC 2 0.0097
48 ALOPECIA TOTALIS 3 0.0091
49 NEUROPSYCHIATRIC SYNDROME 2 0.0091
50 ECTROPION 3 0.0089
51 KERATOACANTHOMA 6 0.0088
52 PITYRIASIS RUBRA PILARIS 2 0.0084
53 PNEUMOTHORAX TRAUMATIC 2 0.0083
54 CHEMICAL BURN OF GENITALIA 1 0.0082
55 GENITAL ERYTHEMA 4 0.0081
56 SKIN EROSION 26 0.0081
57 PENILE ERYTHEMA 3 0.0080
58 ACTINIC KERATOSIS 20 0.0077
59 CERVIX CARCINOMA STAGE III 1 0.0076
60 BOWEN'S DISEASE 1 0.0074
61 LICHENIFICATION 3 0.0073
62 BULBAR PALSY 2 0.0072
63 APPLICATION SITE DISCOLOURATION 29 0.0071
64 SCAB 77 0.0067
65 ANOGENITAL DYSPLASIA 1 0.0067
66 APPLICATION SITE HAEMORRHAGE 18 0.0066
67 ANAL SQUAMOUS CELL CARCINOMA 2 0.0065
68 WOUND INFECTION PSEUDOMONAS 2 0.0064
69 CHROMOSOMAL DELETION 1 0.0063
70 ACTIVITIES OF DAILY LIVING DECREASED 4 0.0063
71 APPLICATION SITE OEDEMA 2 0.0062
72 APPLICATION SITE WOUND 1 0.0061
73 PAPILLOMA VIRAL INFECTION 10 0.0061
74 APPLICATION SITE INFECTION 3 0.0059
75 APPLICATION SITE INDURATION 1 0.0059
76 LIP EROSION 4 0.0055
77 APPLICATION SITE PUSTULES 2 0.0055
78 B-LYMPHOCYTE COUNT INCREASED 1 0.0054
79 APPLICATION SITE INJURY 1 0.0053
80 APPLICATION SITE SWELLING 25 0.0050
81 LIP BLISTER 13 0.0048
82 CUTANEOUS SARCOIDOSIS 2 0.0046
83 COLORECTAL ADENOCARCINOMA 1 0.0045
84 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 1 0.0041
85 BRAIN STEM SYNDROME 3 0.0040
86 SKIN PAPILLOMA 16 0.0040
87 CHRONIC DISEASE 1 0.0039
88 APPLICATION SITE ERYTHEMA 102 0.0039
89 KELOID SCAR 2 0.0039
90 CONJUNCTIVITIS VIRAL 1 0.0038
91 APPLICATION SITE PAPULES 4 0.0038
92 LIP ERYTHEMA 3 0.0038
93 CORNEAL EROSION 2 0.0037
94 ERYTHRODERMIC PSORIASIS 3 0.0036
95 CHEMICAL BURNS OF EYE 1 0.0036
96 INTRACRANIAL HAEMATOMA 2 0.0036
97 LIP PAIN 10 0.0035
98 METASTATIC MALIGNANT MELANOMA 8 0.0035
99 EYE ULCER 2 0.0035
100 CHEMICAL BURN 4 0.0035
101 APPLICATION SITE PAIN 75 0.0034
102 APPLICATION SITE VESICLES 22 0.0034
103 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 6 0.0034
104 MEAN PLATELET VOLUME INCREASED 2 0.0033
105 APPLICATION SITE HYPERSENSITIVITY 4 0.0033
106 HUMAN HERPESVIRUS 8 INFECTION 2 0.0033
107 PUNCTATE KERATITIS 3 0.0033
108 ORAL MUCOSA EROSION 4 0.0033
109 APPLICATION SITE DRYNESS 11 0.0032
110 XEROSIS 4 0.0032
111 ARTERITIS 2 0.0032
112 LIP HAEMORRHAGE 4 0.0031
113 APPLICATION SITE REACTION 22 0.0031
114 ANAL CANCER 3 0.0031
115 CUTANEOUS LUPUS ERYTHEMATOSUS 6 0.0031
116 ADMINISTRATION SITE SWELLING 1 0.0031
117 ACANTHOSIS 1 0.0030
118 HYPERAEMIA 6 0.0030
119 QUADRIPARESIS 5 0.0030
120 CAROTID ARTERY ANEURYSM 1 0.0029
121 APPLICATION SITE EXFOLIATION 12 0.0029
122 WOUND SECRETION 11 0.0028
123 APPLICATION SITE DISCOMFORT 5 0.0028
124 SKIN REACTION 39 0.0028
125 ANKLE ARTHROPLASTY 1 0.0028
126 ESCHAR 2 0.0027
127 PRECANCEROUS SKIN LESION 4 0.0027
128 PATHOGEN RESISTANCE 24 0.0026
129 GENITAL ULCERATION 2 0.0026
130 LIP ULCERATION 3 0.0026
131 PURULENCE 5 0.0026
132 VITILIGO 6 0.0026
133 SQUAMOUS CELL CARCINOMA OF SKIN 15 0.0025
134 BLOOD IMMUNOGLOBULIN G INCREASED 3 0.0025
135 BALANOPOSTHITIS 2 0.0024
136 MYCOSIS FUNGOIDES 2 0.0024
137 MALIGNANT MELANOMA IN SITU 3 0.0024
138 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 12 0.0024
139 SKIN PLAQUE 20 0.0024
140 APPLICATION SITE WARMTH 3 0.0024
141 CORONA VIRUS INFECTION 1 0.0023
142 RENAL TUBULAR ACIDOSIS 5 0.0023
143 SKIN HYPOPIGMENTATION 4 0.0023
144 LIP EXFOLIATION 3 0.0023
145 BASAL CELL CARCINOMA 34 0.0022
146 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0022
147 LICHEN PLANUS 5 0.0022
148 ERYTHEMA MULTIFORME 20 0.0021
149 APPLICATION SITE IRRITATION 26 0.0021
150 TELANGIECTASIA 2 0.0021
151 DUODENAL PERFORATION 2 0.0020
152 GENITAL PAIN 3 0.0020
153 DERMATITIS INFECTED 1 0.0020
154 IMPETIGO 3 0.0020
155 HYPERPARATHYROIDISM SECONDARY 5 0.0020
156 THERAPY PARTIAL RESPONDER 31 0.0020
157 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 3 0.0020
158 AORTIC VALVE CALCIFICATION 1 0.0019
159 CONJUNCTIVAL OEDEMA 2 0.0019
160 SKIN ULCER 49 0.0019
161 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
162 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5 0.0019
163 CHEILITIS 10 0.0018
164 HYPERKERATOSIS 10 0.0018
165 BLOOD PH INCREASED 1 0.0018
166 SQUAMOUS CELL CARCINOMA 17 0.0018
167 LINEAR IGA DISEASE 3 0.0018
168 AORTIC DILATATION 2 0.0018
169 GASTROINTESTINAL ULCER HAEMORRHAGE 2 0.0018
170 BLOODY DISCHARGE 2 0.0017
171 INTERNATIONAL NORMALISED RATIO ABNORMAL 6 0.0017
172 SKIN WEEPING 6 0.0017
173 BLOOD VISCOSITY INCREASED 1 0.0017
174 BLOOD IMMUNOGLOBULIN M INCREASED 1 0.0016
175 VULVOVAGINAL SWELLING 3 0.0016
176 STAPHYLOCOCCAL SKIN INFECTION 2 0.0016
177 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 4 0.0016
178 MULTIPLE-DRUG RESISTANCE 5 0.0016
179 ARTHRITIS REACTIVE 1 0.0016
180 INFECTED SKIN ULCER 3 0.0016
181 LIP DISCOLOURATION 2 0.0016
182 SKIN NECROSIS 8 0.0015
183 HERPES SIMPLEX 10 0.0015
184 APPLICATION SITE PARAESTHESIA 2 0.0015
185 HYPOGEUSIA 3 0.0015
186 DEAFNESS NEUROSENSORY 5 0.0015
187 NEPHROGENIC ANAEMIA 7 0.0015
188 CUTANEOUS SYMPTOM 1 0.0015
189 INTESTINAL MASS 2 0.0015
190 APPLICATION SITE PRURITUS 33 0.0015
191 PEMPHIGUS 18 0.0014
192 ALCOHOL INTOLERANCE 1 0.0014
193 APALLIC SYNDROME 1 0.0014
194 BENIGN NEOPLASM OF THYROID GLAND 1 0.0014
195 LEUKOENCEPHALOPATHY 5 0.0013
196 LICHENOID KERATOSIS 3 0.0013
197 APHTHOUS STOMATITIS 3 0.0013
198 NEUROLOGICAL DECOMPENSATION 3 0.0013
199 NEOPLASM SKIN 2 0.0013
200 BLOOD ALCOHOL INCREASED 1 0.0013
201 TRANSCRIPTION MEDICATION ERROR 2 0.0013
202 BLISTER INFECTED 1 0.0013
203 INFLUENZA LIKE ILLNESS 103 0.0013
204 CHEMICAL INJURY 1 0.0012
205 ANAL ULCER 1 0.0012
206 LUPUS-LIKE SYNDROME 11 0.0012
207 PENIS DISORDER 3 0.0012
208 CIRCADIAN RHYTHM SLEEP DISORDER 1 0.0012
209 DRUG RESISTANCE 31 0.0012
210 WOUND INFECTION STAPHYLOCOCCAL 2 0.0012
211 OTORRHOEA 2 0.0011
212 BURNS SECOND DEGREE 2 0.0011
213 FANCONI SYNDROME ACQUIRED 2 0.0011
214 CEREBELLAR ATROPHY 1 0.0011
215 PIGMENTATION DISORDER 7 0.0011
216 SKIN LESION 31 0.0011
217 CONJUNCTIVAL HYPERAEMIA 4 0.0011
218 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 8 0.0011
219 ARTERIOVENOUS MALFORMATION 1 0.0011
220 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 1 0.0011
221 ADENOCARCINOMA GASTRIC 1 0.0011
222 PLASMACYTOMA 2 0.0011
223 APPLICATION SITE DERMATITIS 1 0.0011
224 SKIN HYPERTROPHY 3 0.0011
225 BUNDLE BRANCH BLOCK 1 0.0011
226 BRAIN STEM HAEMORRHAGE 1 0.0011
227 ECONOMIC PROBLEM 16 0.0011
228 CANCER SURGERY 1 0.0010
229 APHTHOUS ULCER 8 0.0010
230 SKIN IRRITATION 47 0.0010
231 COLON ADENOMA 1 0.0010
232 APPLICATION SITE BURN 5 0.0010
233 CELL DEATH 2 0.0010
234 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 55 0.0010
235 BLOOD IMMUNOGLOBULIN M DECREASED 1 0.0010
236 PAPULE 7 0.0010
237 CAROTID ARTERIOSCLEROSIS 1 0.0010
238 ALVEOLITIS ALLERGIC 1 0.0010
239 CAPILLARY LEAK SYNDROME 2 0.0010
240 SKIN INDURATION 2 0.0010
241 LUNG ABSCESS 2 0.0010
242 CATATONIA 5 0.0010
243 ANHEDONIA 25 0.0010
244 BURNS THIRD DEGREE 1 0.0009
245 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
246 AMAUROSIS FUGAX 1 0.0009
247 GRAFT VERSUS HOST DISEASE IN SKIN 2 0.0009
248 PRODUCT PHYSICAL CONSISTENCY ISSUE 5 0.0009
249 ERYTHEMA 185 0.0009
250 TONGUE BLISTERING 2 0.0009
251 DISTRIBUTIVE SHOCK 2 0.0009
252 HAEMATOCRIT INCREASED 2 0.0009
253 ACUTE PRERENAL FAILURE 1 0.0009
254 PRURITUS GENITAL 2 0.0008
255 WRONG DOSE 2 0.0008
256 PANNICULITIS 2 0.0008
257 ULCER 13 0.0008
258 VIRAL MUTATION IDENTIFIED 3 0.0008
259 STEVENS-JOHNSON SYNDROME 18 0.0008
260 BLOOD UREA DECREASED 1 0.0008
261 ALLERGY TO CHEMICALS 1 0.0008
262 CUTANEOUS T-CELL LYMPHOMA 1 0.0008
263 CARDIOTOXICITY 7 0.0008
264 OEDEMA 42 0.0008
265 ANION GAP INCREASED 1 0.0007
266 B-LYMPHOCYTE COUNT DECREASED 1 0.0007
267 GASTRIC PERFORATION 2 0.0007
268 CALCULUS BLADDER 1 0.0007
269 CORNEAL OPACITY 1 0.0007
270 SELF-MEDICATION 3 0.0007
271 HYPERURICAEMIA 3 0.0007
272 OSTEOPENIA 11 0.0007
273 LIP SWELLING 24 0.0007
274 CHOLECYSTITIS INFECTIVE 2 0.0007
275 PRODUCT USE IN UNAPPROVED INDICATION 177 0.0007
276 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 13 0.0007
277 IMMUNE THROMBOCYTOPENIC PURPURA 2 0.0007
278 TONGUE DISCOMFORT 3 0.0007
279 PURULENT DISCHARGE 3 0.0007
280 CEREBELLAR HAEMORRHAGE 1 0.0007
281 INFLAMMATION 36 0.0007
282 PHARYNGEAL DISORDER 2 0.0007
283 CHAPPED LIPS 3 0.0007
284 MOTOR DYSFUNCTION 7 0.0007
285 RASH PUSTULAR 5 0.0007
286 VULVOVAGINAL DISCOMFORT 3 0.0007
287 FACIAL PAIN 6 0.0007
288 ORAL PAIN 15 0.0007
289 ATYPICAL PNEUMONIA 2 0.0007
290 SCRATCH 7 0.0007
291 KERATITIS 2 0.0007
292 PROSTATITIS 2 0.0007
293 LYMPHADENOPATHY 23 0.0006
294 ORAL DISCOMFORT 9 0.0006
295 PRODUCT PRESCRIBING ISSUE 14 0.0006
296 BLISTER 36 0.0006
297 BACTERIAL VAGINOSIS 1 0.0006
298 SECRETION DISCHARGE 8 0.0006
299 SKIN TIGHTNESS 3 0.0006
300 SKIN ABRASION 3 0.0006
301 PHOTOPSIA 4 0.0006
302 POLYMYALGIA RHEUMATICA 2 0.0006
303 VULVOVAGINAL PAIN 3 0.0006
304 COLON CANCER METASTATIC 1 0.0006
305 ACUTE LEUKAEMIA 1 0.0006
306 COSTOCHONDRITIS 1 0.0006
307 DERMATITIS CONTACT 7 0.0006
308 LYMPHOCYTE COUNT INCREASED 2 0.0006
309 SKIN INJURY 2 0.0006
310 END STAGE RENAL DISEASE 11 0.0006
311 EYELID OEDEMA 7 0.0006
312 HEPATIC ENZYME ABNORMAL 3 0.0006
313 BK VIRUS INFECTION 2 0.0006
314 CLOSTRIDIAL INFECTION 2 0.0006
315 B-CELL LYMPHOMA 2 0.0006
316 SCAR 10 0.0006
317 BLOOD CHLORIDE INCREASED 1 0.0006
318 TENDERNESS 6 0.0006
319 ALOPECIA AREATA 1 0.0006
320 SKIN DISORDER 19 0.0006
321 DERMATITIS BULLOUS 4 0.0006
322 BLOOD HIV RNA INCREASED 1 0.0006
323 SPONDYLITIS 2 0.0005
324 CHILLS 64 0.0005
325 CONDUCTION DISORDER 1 0.0005
326 BODY TEMPERATURE ABNORMAL 1 0.0005
327 WOUND HAEMORRHAGE 2 0.0005
328 NECROSIS 3 0.0005
329 PROTEIN TOTAL DECREASED 2 0.0005
330 PAROSMIA 4 0.0005
331 BLOOD BICARBONATE DECREASED 1 0.0005
332 MOUTH ULCERATION 11 0.0005
333 HERPES VIRUS INFECTION 3 0.0005
334 PRODUCT LABEL CONFUSION 3 0.0005
335 ATROPHY 1 0.0005
336 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
337 ORAL HERPES 10 0.0005
338 RENAL TUBULAR NECROSIS 5 0.0005
339 TRIGEMINAL NEURALGIA 2 0.0005
340 RASH PAPULAR 11 0.0005
341 DERMATITIS PSORIASIFORM 1 0.0005
342 THERAPY NON-RESPONDER 22 0.0005
343 ANAL PRURITUS 1 0.0005
344 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
345 SKIN EXFOLIATION 40 0.0005
346 SKIN HAEMORRHAGE 7 0.0005
347 EYE IRRITATION 27 0.0005
348 HEPATIC PAIN 2 0.0005
349 PSEUDOMONAS INFECTION 4 0.0005
350 BLOOD TESTOSTERONE INCREASED 1 0.0005
351 SKIN SWELLING 4 0.0005
352 CHRONIC KIDNEY DISEASE 35 0.0005
353 CERVICAL DYSPLASIA 1 0.0005
354 GINGIVAL SWELLING 2 0.0005
355 ADVERSE REACTION 6 0.0005
356 EJECTION FRACTION DECREASED 7 0.0004
357 WHEELCHAIR USER 2 0.0004
358 NERVE INJURY 5 0.0004
359 BONE DENSITY DECREASED 14 0.0004
360 SKIN INFECTION 5 0.0004
361 APPLICATION SITE URTICARIA 1 0.0004
362 BLOOD LOSS ANAEMIA 1 0.0004
363 LIP DRY 4 0.0004
364 URINE ABNORMALITY 2 0.0004
365 HAEMOGLOBIN INCREASED 2 0.0004
366 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
367 CYTOMEGALOVIRUS COLITIS 1 0.0004
368 MULTIPLE FRACTURES 7 0.0004
369 DUODENAL ULCER 3 0.0004
370 STAPHYLOCOCCAL INFECTION 14 0.0004
371 HAND FRACTURE 3 0.0004
372 THERMAL BURN 3 0.0004
373 RETCHING 9 0.0004
374 BLOOD IRON DECREASED 5 0.0004
375 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
376 TREATMENT FAILURE 34 0.0004
377 CARTILAGE INJURY 1 0.0004
378 STAPHYLOCOCCAL SEPSIS 2 0.0004
379 HYPERVOLAEMIA 2 0.0004
380 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
381 BLOOD COUNT ABNORMAL 6 0.0004
382 CHEMICAL BURN OF SKIN 1 0.0004
383 APPENDICITIS PERFORATED 1 0.0004
384 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
385 INCREASED UPPER AIRWAY SECRETION 2 0.0004
386 GAIT INABILITY 13 0.0004
387 DRUG ADMINISTERED AT INAPPROPRIATE SITE 4 0.0004
388 RENAL CYST 3 0.0004
389 TRANSPLANT REJECTION 3 0.0004
390 BLOOD DISORDER 3 0.0004
391 MALIGNANT MELANOMA 5 0.0004
392 SENSORY LOSS 3 0.0004
393 VIROLOGIC FAILURE 2 0.0004
394 PAIN OF SKIN 10 0.0004
395 BURNING SENSATION 26 0.0004
396 APPLICATION SITE RASH 5 0.0004
397 DEAFNESS UNILATERAL 2 0.0004
398 SECOND PRIMARY MALIGNANCY 3 0.0004
399 STREPTOCOCCAL INFECTION 2 0.0004
400 SKIN FISSURES 7 0.0004
401 NEPHROPATHY TOXIC 4 0.0004
402 BLOOD PRESSURE ABNORMAL 7 0.0004
403 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 25 0.0004
404 SKIN HYPERPIGMENTATION 3 0.0003
405 ANURIA 3 0.0003
406 IMPAIRED QUALITY OF LIFE 5 0.0003
407 SKIN ATROPHY 2 0.0003
408 MOUTH SWELLING 2 0.0003
409 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10 0.0003
410 RIB FRACTURE 7 0.0003
411 ENERGY INCREASED 2 0.0003
412 SYSTEMIC LUPUS ERYTHEMATOSUS 12 0.0003
413 OSTEONECROSIS 11 0.0003
414 RASH ERYTHEMATOUS 16 0.0003
415 DERMATITIS 7 0.0003
416 BONE LOSS 5 0.0003
417 BLOOD PRESSURE INADEQUATELY CONTROLLED 2 0.0003
418 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
419 TOXIC EPIDERMAL NECROLYSIS 5 0.0003
420 RETINAL DETACHMENT 3 0.0003
421 IRON DEFICIENCY ANAEMIA 3 0.0003
422 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 2 0.0003
423 EYE SWELLING 12 0.0003
424 DEMENTIA 9 0.0003
425 FLANK PAIN 3 0.0003
426 BLOOD CREATININE DECREASED 1 0.0003
427 LACERATION 3 0.0003
428 SWELLING OF EYELID 2 0.0003
429 SPINAL DISORDER 3 0.0003
430 OSTEOPOROSIS 13 0.0003
431 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
432 BLADDER PAIN 1 0.0003
433 ANGINA PECTORIS 9 0.0003
434 TREATMENT NONCOMPLIANCE 17 0.0003
435 DYSGEUSIA 23 0.0003
436 EAR PAIN 6 0.0003
437 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
438 BEDRIDDEN 4 0.0003
439 OFF LABEL USE 265 0.0003
440 HYPONATRAEMIA 17 0.0003
441 APPETITE DISORDER 2 0.0003
442 SKIN MASS 2 0.0003
443 ANXIETY DISORDER 1 0.0003
444 EYE PRURITUS 10 0.0003
445 HERPES ZOSTER 17 0.0003
446 TASTE DISORDER 6 0.0003
447 ULCER HAEMORRHAGE 2 0.0003
448 DISEASE RECURRENCE 14 0.0003
449 MYALGIA 50 0.0003
450 EUPHORIC MOOD 3 0.0003
451 SKELETAL INJURY 3 0.0003
452 EYE DISCHARGE 3 0.0003
453 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
454 AUTOIMMUNE HEPATITIS 2 0.0003
455 AORTIC STENOSIS 1 0.0003
456 CAROTID ARTERY STENOSIS 1 0.0003
457 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
458 SKIN DISCOLOURATION 13 0.0003
459 NIGHT SWEATS 9 0.0003
460 SKIN CANCER 6 0.0003
461 DECREASED ACTIVITY 3 0.0003
462 VISUAL FIELD DEFECT 2 0.0003
463 BACK INJURY 3 0.0003
464 APATHY 4 0.0003
465 INTENTIONAL UNDERDOSE 2 0.0003
466 MAJOR DEPRESSION 2 0.0003
467 ORAL DISORDER 2 0.0003
468 MOUTH HAEMORRHAGE 2 0.0003
469 TRANSAMINASES INCREASED 6 0.0003
470 SUNBURN 2 0.0003
471 PEMPHIGOID 2 0.0003
472 LACRIMATION INCREASED 8 0.0003
473 EMOTIONAL DISTRESS 32 0.0003
474 POLLAKIURIA 11 0.0003
475 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
476 CLAVICLE FRACTURE 1 0.0003
477 MADAROSIS 3 0.0003
478 MUSCULOSKELETAL CHEST PAIN 4 0.0003
479 APNOEA 2 0.0003
480 BRAIN FOG 4 0.0003
481 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
482 BACTERAEMIA 3 0.0003
483 NASAL DISCOMFORT 2 0.0003
484 RESPIRATORY TRACT CONGESTION 4 0.0003
485 GINGIVAL PAIN 2 0.0003
486 UPPER LIMB FRACTURE 5 0.0003
487 WOUND 7 0.0003
488 AZOTAEMIA 1 0.0003
489 PRODUCT USE ISSUE 47 0.0002
490 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
491 INCORRECT DRUG ADMINISTRATION DURATION 7 0.0002
492 CYSTITIS HAEMORRHAGIC 1 0.0002
493 STOMATITIS 15 0.0002
494 VERTIGO 15 0.0002
495 SWELLING FACE 16 0.0002
496 PYREXIA 85 0.0002
497 DISEASE PROGRESSION 29 0.0002
498 HYPERAESTHESIA 2 0.0002
499 MANIA 4 0.0002
500 TINNITUS 11 0.0002
501 OROPHARYNGEAL PAIN 22 0.0002
502 ATTENTION DEFICIT HYPERACTIVITY DISORDER 1 0.0002
503 CANDIDA INFECTION 4 0.0002
504 DECREASED APPETITE 55 0.0002
505 COGNITIVE DISORDER 11 0.0002
506 ABSCESS LIMB 1 0.0002
507 RENAL FAILURE 31 0.0002
508 FATIGUE 181 0.0002
509 BLOOD MAGNESIUM DECREASED 2 0.0002
510 SEPTIC SHOCK 10 0.0002
511 LOCAL SWELLING 4 0.0002
512 PRURITUS 88 0.0002
513 RASH MACULAR 8 0.0002
514 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
515 IMMUNE SYSTEM DISORDER 3 0.0002
516 TOOTH INFECTION 3 0.0002
517 IMMUNOSUPPRESSION 2 0.0002
518 PURPURA 2 0.0002
519 LETHARGY 13 0.0002
520 DRUG ERUPTION 4 0.0002
521 EAR INFECTION 6 0.0002
522 DRY SKIN 30 0.0002
523 HEPATOTOXICITY 5 0.0002
524 GLOSSODYNIA 5 0.0002
525 PAIN 137 0.0002
526 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
527 ACUTE KIDNEY INJURY 34 0.0002
528 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 40 0.0002
529 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
530 LEUKOPENIA 11 0.0002
531 ABDOMINAL HERNIA 1 0.0002
532 EXOSTOSIS 2 0.0002
533 PNEUMONIA BACTERIAL 2 0.0002
534 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
535 BACK PAIN 50 0.0002
536 THINKING ABNORMAL 4 0.0002
537 BACTERIAL INFECTION 4 0.0002
538 THERAPY CESSATION 11 0.0002
539 DEFORMITY 2 0.0002
540 SWELLING 20 0.0002
541 DISCOMFORT 13 0.0002
542 BLINDNESS UNILATERAL 3 0.0002
543 ARTERIOSCLEROSIS 2 0.0002
544 FOOT FRACTURE 4 0.0002
545 SPUTUM DISCOLOURED 2 0.0002
546 BLOOD URINE PRESENT 4 0.0002
547 PRODUCT PACKAGING ISSUE 2 0.0002
548 PRODUCT PRESCRIBING ERROR 5 0.0002
549 EYE INFLAMMATION 2 0.0002
550 DRUG PRESCRIBING ERROR 4 0.0002
551 DRUG INTERACTION 33 0.0002
552 APHAGIA 1 0.0002
553 AUTOIMMUNE DISORDER 2 0.0002
554 VITAMIN D DEFICIENCY 2 0.0002
555 CONDITION AGGRAVATED 62 0.0002
556 HOSPICE CARE 2 0.0002
557 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
558 MUSCULAR WEAKNESS 23 0.0002
559 AGEUSIA 5 0.0002
560 DRY EYE 10 0.0002
561 ANXIETY 57 0.0002
562 CORONARY ARTERY STENOSIS 1 0.0002
563 APHASIA 6 0.0002
564 VAGINAL DISCHARGE 2 0.0002
565 FEEDING DISORDER 4 0.0002
566 PSORIATIC ARTHROPATHY 8 0.0002
567 CARDIOVASCULAR DISORDER 5 0.0002
568 PANCYTOPENIA 11 0.0002
569 TOOTH ABSCESS 2 0.0002
570 DRUG DISPENSING ERROR 3 0.0002
571 NEUTROPHIL COUNT INCREASED 2 0.0002
572 CACHEXIA 1 0.0002
573 TEMPERATURE INTOLERANCE 2 0.0002
574 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
575 TOOTH LOSS 4 0.0002
576 DRUG EFFECT INCOMPLETE 7 0.0002
577 SWOLLEN TONGUE 6 0.0002
578 RESPIRATORY TRACT INFECTION 5 0.0002
579 TRANSFUSION 2 0.0002
580 POOR QUALITY PRODUCT ADMINISTERED 2 0.0002
581 DERMATITIS ATOPIC 10 0.0002
582 OCULAR HYPERAEMIA 9 0.0002
583 PNEUMOTHORAX 3 0.0002
584 FULL BLOOD COUNT ABNORMAL 2 0.0002
585 ANORECTAL DISCOMFORT 1 0.0002
586 ABSCESS 3 0.0002
587 MOVEMENT DISORDER 6 0.0002
588 RHINORRHOEA 12 0.0002
589 ANAL ABSCESS 1 0.0002
590 PHARYNGITIS STREPTOCOCCAL 2 0.0002
591 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
592 MENSTRUATION DELAYED 2 0.0002
593 PNEUMONITIS 5 0.0002
594 ASTHENIA 69 0.0002
595 IMPAIRED HEALING 6 0.0002
596 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 13 0.0002
597 WOUND INFECTION 2 0.0002
598 GASTROINTESTINAL PAIN 2 0.0002
599 HAEMORRHAGE 19 0.0002
600 SKIN BURNING SENSATION 13 0.0002
601 DRUG LEVEL INCREASED 3 0.0002
602 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
603 EXPIRED PRODUCT ADMINISTERED 6 0.0002
604 MUSCLE SPASMS 33 0.0002
605 URINARY RETENTION 6 0.0002
606 ADVERSE DRUG REACTION 16 0.0002
607 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
608 CIRCULATORY COLLAPSE 3 0.0002
609 MYOCARDIAL ISCHAEMIA 2 0.0002
610 MICTURITION URGENCY 2 0.0002
611 INTERNAL HAEMORRHAGE 2 0.0002
612 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
613 MULTI-ORGAN FAILURE 3 0.0002
614 DELIRIUM 6 0.0002
615 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
616 MALAISE 75 0.0002
617 SPLENOMEGALY 2 0.0002
618 HYPOXIA 6 0.0002
619 COVID-19 PNEUMONIA 2 0.0002
620 CATARACT OPERATION 1 0.0002
621 ACCIDENT 2 0.0002
622 BURSITIS 2 0.0002
623 DERMATITIS ACNEIFORM 1 0.0002
624 NO THERAPEUTIC RESPONSE 2 0.0002
625 DYSURIA 6 0.0002
626 GAIT DISTURBANCE 31 0.0002
627 CONJUNCTIVITIS 3 0.0002
628 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
629 HAIR COLOUR CHANGES 2 0.0002
630 MIDDLE INSOMNIA 3 0.0002
631 EYE PAIN 9 0.0002
632 BLEPHAROSPASM 1 0.0002
633 HEPATIC CYTOLYSIS 2 0.0002
634 HYPOPHAGIA 4 0.0002
635 CHOLESTASIS 3 0.0002
636 MYDRIASIS 2 0.0002
637 GENITAL HAEMORRHAGE 2 0.0002
638 CARDIAC FLUTTER 1 0.0002
639 RASH GENERALISED 4 0.0002
640 DIPLOPIA 4 0.0002
641 NODULE 2 0.0002
642 DEAFNESS 4 0.0002
643 NEPHROLITHIASIS 7 0.0002
644 INFLUENZA 17 0.0002
645 ORAL CANDIDIASIS 2 0.0002
646 HEADACHE 95 0.0002
647 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
648 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
649 QUALITY OF LIFE DECREASED 2 0.0001
650 FEAR 4 0.0001
651 SINUS CONGESTION 2 0.0001
652 THROAT TIGHTNESS 4 0.0001
653 RASH PRURITIC 8 0.0001
654 BODY TEMPERATURE INCREASED 3 0.0001
655 RASH 64 0.0001
656 GINGIVAL BLEEDING 2 0.0001
657 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
658 NAUSEA 114 0.0001
659 MEDICATION ERROR 8 0.0001
660 APHONIA 2 0.0001
661 URTICARIA 24 0.0001
662 NECK PAIN 8 0.0001
663 MASS 2 0.0001
664 RENAL IMPAIRMENT 12 0.0001
665 BLOOD TEST ABNORMAL 2 0.0001
666 SEASONAL ALLERGY 2 0.0001
667 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
668 PAIN IN JAW 4 0.0001
669 RED BLOOD CELL COUNT DECREASED 4 0.0001
670 POOR QUALITY SLEEP 3 0.0001
671 CELLULITIS 7 0.0001
672 PRURITUS GENERALISED 3 0.0001
673 FAECES DISCOLOURED 3 0.0001
674 MYELODYSPLASTIC SYNDROME 2 0.0001
675 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 28 0.0001
676 ANOSMIA 2 0.0001
677 PSORIASIS 18 0.0001
678 PRODUCT DISPENSING ERROR 3 0.0001
679 ALOPECIA 27 0.0001
680 MUSCULOSKELETAL STIFFNESS 12 0.0001
681 DIZZINESS 68 0.0001
682 NASAL CONGESTION 8 0.0001
683 ILLNESS 14 0.0001
684 ACCIDENTAL EXPOSURE TO PRODUCT 14 0.0001
685 BLINDNESS TRANSIENT 1 0.0001
686 LABORATORY TEST ABNORMAL 4 0.0001
687 CEREBRAL DISORDER 1 0.0001
688 PULMONARY MASS 2 0.0001
689 THROAT IRRITATION 6 0.0001
690 MUSCULOSKELETAL PAIN 7 0.0001
691 ATRIAL FIBRILLATION 13 0.0001
692 CORONARY ARTERY DISEASE 4 0.0001
693 ACNE 10 0.0001
694 AORTIC ANEURYSM 1 0.0001
695 INSOMNIA 35 0.0001
696 VISION BLURRED 18 0.0001
697 INSURANCE ISSUE 2 0.0001
698 HIP ARTHROPLASTY 2 0.0001
699 DRUG ADMINISTRATION ERROR 4 0.0001
700 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
701 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
702 DISTURBANCE IN ATTENTION 7 0.0001
703 THYROID DISORDER 2 0.0001
704 DRUG INEFFECTIVE 171 0.0001
705 ANKLE FRACTURE 2 0.0001
706 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
707 SLEEP DISORDER 9 0.0001
708 AFFECTIVE DISORDER 1 0.0001
709 SINUSITIS 13 0.0001
710 PRODUCTIVE COUGH 6 0.0001
711 INTENTIONAL PRODUCT MISUSE 11 0.0001
712 PAIN IN EXTREMITY 37 0.0001
713 ATRIAL FLUTTER 1 0.0001
714 ARTHRALGIA 52 0.0001
715 LOSS OF CONSCIOUSNESS 16 0.0001
716 HIP FRACTURE 4 0.0001
717 INFECTION 18 0.0001
718 DRUG INTOLERANCE 12 0.0001
719 FLATULENCE 7 0.0001
720 PERIPHERAL SWELLING 19 0.0001
721 DECUBITUS ULCER 1 0.0001
722 AGITATION 9 0.0001
723 ABNORMAL FAECES 1 0.0001
724 BRONCHITIS 9 0.0001
725 PRODUCT SUBSTITUTION ISSUE 7 0.0001
726 ACUTE CORONARY SYNDROME 1 0.0001
727 FUNGAL INFECTION 4 0.0001
728 SYNCOPE 12 0.0001
729 DYSPHONIA 7 0.0001
730 HYPOTENSION 24 0.0001
731 ROAD TRAFFIC ACCIDENT 5 0.0001
732 HALLUCINATION 9 0.0001
733 SURGERY 7 0.0001
734 FACE OEDEMA 2 0.0001
735 HYPERSENSITIVITY 22 0.0001
736 RENAL FAILURE ACUTE 5 0.0001
737 CATARACT 7 0.0001
738 NEUROPATHY PERIPHERAL 11 0.0001
739 ORTHOSTATIC HYPOTENSION 2 0.0001
740 DIARRHOEA 74 0.0001
741 METASTASES TO LIVER 2 0.0001
742 CHEST PAIN 21 0.0001
743 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
744 LYMPHOCYTE COUNT DECREASED 2 0.0001
745 HEAD DISCOMFORT 2 0.0001
746 THIRST 2 0.0001
747 GOUT 2 0.0001
748 PNEUMONIA 36 0.0001
749 GASTROENTERITIS VIRAL 2 0.0001
750 BONE DISORDER 2 0.0001
751 RESPIRATORY DISTRESS 3 0.0001
752 ABNORMAL DREAMS 3 0.0001
753 WEIGHT DECREASED 30 0.0001
754 PRODUCT DOSE OMISSION 7 0.0001
755 BLOOD CREATININE INCREASED 7 0.0001
756 APPENDICITIS 1 0.0001
757 PHOTOPHOBIA 2 0.0001
758 DYSPNOEA EXERTIONAL 4 0.0001
759 BLOOD SODIUM DECREASED 2 0.0001
760 DEPRESSION 24 0.0001
761 PULMONARY EMBOLISM 10 0.0001
762 INTENTIONAL DOSE OMISSION 3 0.0001
763 FEELING JITTERY 2 0.0001
764 INCREASED APPETITE 2 0.0001
765 HYPERSOMNIA 3 0.0001
766 PULMONARY FIBROSIS 2 0.0001
767 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
768 BALANCE DISORDER 9 0.0001
769 HEPATIC ENZYME INCREASED 7 0.0001
770 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
771 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
772 BODY TEMPERATURE DECREASED 1 0.0001
773 ABDOMINAL DISCOMFORT 17 0.0001
774 URINARY INCONTINENCE 3 0.0001
775 WHEEZING 6 0.0001
776 RENAL INJURY 3 0.0001
777 HYPERHIDROSIS 13 0.0001
778 HAEMATOCRIT DECREASED 2 0.0001
779 RESPIRATORY DISORDER 3 0.0001
780 SPINAL FRACTURE 2 0.0001
781 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
782 PRODUCT PHYSICAL ISSUE 2 0.0001
783 PLEURAL EFFUSION 6 0.0001
784 BLINDNESS 4 0.0001
785 NEUTROPHIL COUNT DECREASED 4 0.0001
786 EPILEPSY 3 0.0001
787 FEELING HOT 6 0.0001
788 DEHYDRATION 13 0.0001
789 LIMB DISCOMFORT 3 0.0001
790 VISUAL IMPAIRMENT 12 0.0001
791 PERITONITIS 2 0.0001
792 NEUTROPENIA 13 0.0001
793 DYSPHAGIA 9 0.0001
794 HALLUCINATION, VISUAL 2 0.0001
795 DEPRESSED MOOD 5 0.0001
796 ANAEMIA 18 0.0001
797 MIGRAINE 9 0.0001
798 PLATELET COUNT DECREASED 10 0.0001
799 BREAST PAIN 1 0.0001
800 IMPAIRED WORK ABILITY 2 0.0001
801 IRRITABLE BOWEL SYNDROME 2 0.0001
802 COUGH 26 0.0001
803 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
804 ABDOMINAL PAIN UPPER 19 0.0001
805 WHITE BLOOD CELL COUNT DECREASED 10 0.0001
806 BIPOLAR DISORDER 1 0.0001
807 DIABETES MELLITUS 7 0.0001
808 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
809 ASPIRATION 1 0.0001
810 EYE DISORDER 3 0.0001
811 TOOTH DISORDER 2 0.0001
812 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
813 SNEEZING 2 0.0001
814 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
815 ASTHMA 10 0.0001
816 HAEMOGLOBIN DECREASED 9 0.0001
817 FALL 29 0.0001
818 GENERAL PHYSICAL HEALTH DETERIORATION 10 0.0001
819 DRY MOUTH 7 0.0001
820 ABDOMINAL PAIN 20 0.0001
821 COVID-19 15 0.0001
822 HYPERTENSION 18 0.0001
823 DYSPNOEA 48 0.0001
824 ARRHYTHMIA 4 0.0001
825 ATAXIA 1 0.0001
826 MULTIPLE SCLEROSIS 4 0.0001
827 IRRITABILITY 5 0.0001
828 PARAESTHESIA 13 0.0001
829 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
830 CRYING 3 0.0001
831 CONSTIPATION 18 0.0001
832 MENTAL IMPAIRMENT 2 0.0001
833 THERAPEUTIC RESPONSE DECREASED 5 0.0001
834 NEURALGIA 2 0.0001
835 CYTOPENIA 1 0.0001
836 LUNG DISORDER 4 0.0001
837 PRODUCT DOSE OMISSION ISSUE 24 0.0001
838 ABASIA 2 0.0001
839 SEPSIS 9 0.0001
840 HYPOAESTHESIA 12 0.0001
841 PRODUCT STORAGE ERROR 7 0.0001
842 INTESTINAL OBSTRUCTION 3 0.0001
843 UNEVALUABLE EVENT 6 0.0001
844 FEELING ABNORMAL 19 0.0001
845 BRAIN OEDEMA 1 0.0001
846 FLUSHING 8 0.0001
847 FLUID RETENTION 4 0.0001
848 MALIGNANT NEOPLASM PROGRESSION 8 0.0001
849 HAEMATOMA 2 0.0001
850 VOMITING 36 0.0001
851 JOINT STIFFNESS 2 0.0001
852 URINARY TRACT INFECTION 13 0.0001
853 NASOPHARYNGITIS 14 0.0001
854 BRADYCARDIA 4 0.0001
855 NEOPLASM MALIGNANT 5 0.0001
856 LIMB INJURY 2 0.0001
857 PRODUCT QUALITY ISSUE 10 0.0001
858 MOOD ALTERED 2 0.0001
859 DIVERTICULITIS 2 0.0001
860 ARTHROPATHY 4 0.0001
861 RHABDOMYOLYSIS 3 0.0001
862 CARPAL TUNNEL SYNDROME 1 0.0001
863 DYSPEPSIA 7 0.0001
864 OSTEOARTHRITIS 3 0.0001
865 THERAPY INTERRUPTED 5 0.0001
866 CARDIOGENIC SHOCK 1 0.0001
867 MOBILITY DECREASED 5 0.0001
868 VAGINAL HAEMORRHAGE 3 0.0001
869 NEEDLE ISSUE 2 0.0001
870 DYSSTASIA 2 0.0001
871 BONE PAIN 4 0.0001
872 ASCITES 2 0.0001
873 CARDIOMYOPATHY 1 0.0001
874 PULMONARY OEDEMA 3 0.0001
875 GASTROINTESTINAL DISORDER 6 0.0001
876 BLOOD POTASSIUM DECREASED 2 0.0001
877 JOINT SWELLING 8 0.0001
878 NO ADVERSE EVENT 12 0.0001
879 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
880 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
881 ADVERSE EVENT 6 0.0001
882 HYPOKALAEMIA 3 0.0001
883 SOMNOLENCE 13 0.0001
884 RENAL DISORDER 3 0.0001
885 ACUTE MYELOID LEUKAEMIA 1 0.0001
886 HEAD INJURY 2 0.0001
887 CARDIAC FAILURE CONGESTIVE 5 0.0001
888 BACK DISORDER 1 0.0001
889 AMNESIA 4 0.0001
890 CHOLELITHIASIS 2 0.0001
891 VISUAL ACUITY REDUCED 2 0.0001
892 CYTOMEGALOVIRUS INFECTION 1 0.0001
893 VIRAL INFECTION 2 0.0001
894 PALPITATIONS 7 0.0001
895 BLOOD UREA INCREASED 1 0.0001
896 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
897 CHEST DISCOMFORT 6 0.0001
898 HAEMATURIA 2 0.0001
899 INJECTION SITE REACTION 4 0.0001
900 NIGHTMARE 2 0.0001
901 NEOPLASM PROGRESSION 2 0.0001
902 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
903 OEDEMA PERIPHERAL 7 0.0001
904 NERVOUSNESS 3 0.0001
905 ECZEMA 3 0.0001
906 HEART RATE DECREASED 2 0.0001
907 DEVICE MALFUNCTION 4 0.0001
908 PANCREATITIS 3 0.0001
909 COLD SWEAT 1 0.0001
910 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
911 INJECTION SITE ERYTHEMA 7 0.0001
912 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
913 CEREBRAL HAEMORRHAGE 2 0.0001
914 CONFUSIONAL STATE 9 0.0001
915 RESPIRATORY FAILURE 4 0.0001
916 ACCIDENTAL OVERDOSE 2 0.0001
917 DRUG DOSE OMISSION 9 0.0001
918 TREMOR 9 0.0001
919 OXYGEN SATURATION DECREASED 3 0.0001
920 INCORRECT DOSE ADMINISTERED 12 0.0001
921 CONTUSION 5 0.0001
922 ARTHRITIS 4 0.0001
923 ABNORMAL BEHAVIOUR 2 0.0001
924 HEART RATE INCREASED 5 0.0001
925 CYTOKINE RELEASE SYNDROME 1 0.0000
926 THROMBOSIS 4 0.0000
927 EXTRA DOSE ADMINISTERED 2 0.0000
928 BONE MARROW FAILURE 1 0.0000
929 CARDIAC ARREST 4 0.0000
930 ABDOMINAL DISTENSION 5 0.0000
931 HYPOACUSIS 2 0.0000
932 DEVICE DISLOCATION 2 0.0000
933 MENTAL DISORDER 2 0.0000
934 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
935 FEBRILE NEUTROPENIA 3 0.0000
936 ANGIOEDEMA 2 0.0000
937 LIVER DISORDER 2 0.0000
938 TACHYCARDIA 4 0.0000
939 THROMBOCYTOPENIA 5 0.0000
940 CHROMATURIA 1 0.0000
941 SUICIDAL IDEATION 4 0.0000
942 COMA 2 0.0000
943 OVERDOSE 9 0.0000
944 BLOOD GLUCOSE DECREASED 2 0.0000
945 INTERSTITIAL LUNG DISEASE 2 0.0000
946 HYPOGLYCAEMIA 2 0.0000
947 EPISTAXIS 3 0.0000
948 AGGRESSION 2 0.0000
949 BLOOD PRESSURE INCREASED 6 0.0000
950 SPEECH DISORDER 2 0.0000
951 BREAST CANCER FEMALE 1 0.0000
952 BLOOD BILIRUBIN INCREASED 1 0.0000
953 HAEMATOCHEZIA 2 0.0000
954 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
955 INJECTION SITE PAIN 11 0.0000
956 WEIGHT INCREASED 8 0.0000
957 DEATH 30 0.0000
958 ACUTE MYOCARDIAL INFARCTION 1 0.0000
959 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
960 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
961 ILL-DEFINED DISORDER 2 0.0000
962 BREAST CANCER 3 0.0000
963 CYSTITIS 1 0.0000
964 INTENTIONAL OVERDOSE 2 0.0000
965 INFUSION RELATED REACTION 2 0.0000
966 INJECTION SITE PRURITUS 2 0.0000
967 TOXICITY TO VARIOUS AGENTS 5 0.0000
968 ANGER 1 0.0000
969 INJURY 2 0.0000
970 C-REACTIVE PROTEIN INCREASED 1 0.0000
971 HOT FLUSH 2 0.0000
972 RHEUMATOID ARTHRITIS 3 0.0000
973 COLITIS 1 0.0000
974 HOSPITALISATION 4 0.0000
975 SEIZURE 3 0.0000
976 INJECTION SITE HAEMORRHAGE 2 0.0000
977 CARDIO-RESPIRATORY ARREST 1 0.0000
978 CEREBROVASCULAR ACCIDENT 4 0.0000
979 MYOCARDIAL INFARCTION 4 0.0000
980 BLOOD CHOLESTEROL INCREASED 1 0.0000
981 CARDIAC DISORDER 2 0.0000
982 ANAPHYLACTIC REACTION 1 0.0000
983 BLOOD GLUCOSE INCREASED 3 0.0000
984 DEEP VEIN THROMBOSIS 1 0.0000
985 BLOOD PRESSURE DECREASED 1 0.0000
986 MEMORY IMPAIRMENT 2 0.0000
987 DRUG DEPENDENCE 2 0.0000